People · Operator
Named in public records as an officer, director or promoter · active 2013–2016 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ApoGen Biotechnologies, Inc. | — | Biotechnology | Series A | $7.6M | $273.5M | 2016 |
| Oncofactor Corp | — | Biotechnology | Seed | $3.1M | $44.4M | 2013 |
David McElligott at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David McElligott on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steve Gillis | 2 | 13 |
| Thong Le | 2 | 12 |
| Lindsay Rayle | 2 | 7 |
| David Schubert | 2 | 6 |
| Asish Xavier | 1 | 18 |
| Chad Waite | 1 | 11 |
| Joel Marcus | 1 | 9 |
| Carl Weissman | 1 | 8 |
| James Sullivan | 1 | 7 |
| Lee Babiss | 1 | 5 |
| M. Johnston Erwin | 1 | 5 |
| Joel Johnston Marcus | 1 | 5 |
| John Santini | 1 | 5 |
| Janis Naeve | 1 | 3 |
| James Johnston Sullivan | 1 | 3 |
| Ian A.W. Howes | 1 | 2 |
| Keno Gutierrez | 1 | 2 |
| John Johnston Santini | 1 | 1 |
| Johnston Erwin | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.